secwatch.observer — SEC 8-K summary
======================================

Issuer:     KYNTRA BIO, INC. (KYNB)
CIK:        0000921299
Form:       8-K
Filed at:   2023-10-27T23:59:59+00:00
Accession:  0000950170-23-056018
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

FibroGen receives Nasdaq notice of non-compliance for bid price below $1.00
---------------------------------------------------------------------------

- Closing bid price of FGEN stock below $1.00 for 30 consecutive business days as of Oct 24, 2023.
- Company has 180 calendar days (until April 22, 2024) to regain compliance.
- To regain compliance, bid price must close at $1.00+ for at least 10 consecutive business days.
- If not cured, FibroGen may qualify for an additional 180-day period if other listing standards met.
- FibroGen states it meets all other Nasdaq continued listing requirements except bid price.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/921299/000095017023056018/0000950170-23-056018-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/921299/000095017023056018/fgen-20231024.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-056018

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer